French Registry of Adult Patients With Immune Thrombocytopenia and Autoimmune Hemolytic Anemia
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorUniversity Hospital, Toulouse
About this trial
CARMEN is a national, real-world clinical registry of all adult patients with incident diagnosis of Immune thrombocytopenia (ITP) or Autoimmune Hemolytic anemia (AIHA) patients in France. It is aimed at describing ITP and AIHA clinical features, assessing the real-world risk-benefit ratio of treatments and adherence to guidelines for ITP and AIHA management.
Eligibility criteria
Qualifiers
adult patients (18+ year-old)
newly diagnosed for ITP/AIHA or initiation of FOSFAMATINIB
Disqualifiers
None
Trial design
Treatments tested in this trial
- no specific intervention
Treatment groups
No treatment groups listed
Sponsors and collaborators
Source ClinicalTrials.gov